antimicrobial resistance | pharmaphorum

Saturday 20 December 2025

antimicrobial resistance

R&D

The interconnected web of antimicrobial resistance

One world, one health: The interconnected web of antimicrobi...

Tackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and environmental drivers, consequences, and data.

News

Bacteria-generic-4

Novartis antibiotic retreat doesn’t stop Sandoz buying GSK d...

Novartis exited novel antibiotics R&D three years ago, but is clearly still interested in the category – its Sandoz unit has just spent $350 million buying GlaxoSmithKline’s cephalospor

Partner Content

1200x627 1 week to go

Partner Content

1 week to SMi’s Superbugs & Superdrugs - REMOTE ACCESS ONLY

1 week to Superbugs & Superdrugs - REMOTE ACCESS ONLY

Partner Content

P-312 Superbugs 650x650

Partner Content

Interview with Martin Everett speaker at SMi’s Superbugs & S...

Interview with Martin Everett speaker at Superbugs

News

Brexit Health Alliance warns on infection threat

Still too little progress on antibiotic resistance, says O’N...

News

Bacteria-generic-4

FDA okays Nabriva’s novel antibiotic Xenleta for pneumonia